Skip to main content

Table 5 Logistic regression for death or disease progression at 12 months in patients with FVC ≥ 80%

From: Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

  n OR 95% CI p
Age 216 0.99 0.94 1.05 0.847
male 216 0.86 0.35 2.09 0.739
BMI 212 1.00 0.92 1.10 0.954
Ever smoker 216 0.93 0.34 2.50 0.879
FVC % preda 216 0.81 0.56 1.16 0.241
DLco %preda 216 0.87 0.67 1.14 0.312
CPIa 216 1.26 0.86 1.86 0.234
GAP stage 216 1.12 0.43 2.90 0.813
6 MWDb 63 0.75 0.54 1.04 0.083
SpO2 at start 63 0.86 0.71 1.03 0.108
SpO2 at end 63 0.89 0.81 0.98 0.021
SpO2 nadir 59 0.89 0.81 0.98 0.024
SGRQc 199 1.02 0.93 1.12 0.688
UCSD SOBQa 126 1.00 0.77 1.28 0.970
Cough severitya 177 1.16 0.95 1.41 0.136
  1. BMI body mass index, FVC forced vital capacity, DLco diffusion capacity for carbon monoxide, CPI composite physiological index, GAP gender age physiology, 6MWD 6 min walk distance, SpO2 peripheral blood oxygen saturation, SGRQ St George’s Respiratory Questionniare, UCSD- SOBQ University of California San Diego shortness of breath questionnaire. aFor every 10 unit change; b for every 50 m change; c for every 4 point change